Mabpharm Limited (HKG:2181)
Hong Kong
· Delayed Price · Currency is HKD 0.430
+0.020 (4.88%)
At close: Mar 10, 2026
Mabpharm Market Cap
Mabpharm has a market cap or net worth of 1.69 billion as of March 10, 2026. Its market cap has increased by 41.38% in one year.
Market Cap
1.69B
Enterprise Value
1.92B
Revenue
464.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.43
Market Cap Chart
Since May 31, 2019, Mabpharm's market cap has decreased from 4.99B to 1.69B, a decrease of -66.12%. That is a compound annual growth rate of -14.76%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cutia Therapeutics | 1.71B |
| Zhaoke Ophthalmology | 1.85B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.91B |
| Immunotech Biopharm | 1.45B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.98B |
| Kintor Pharmaceutical | 1.44B |
| CANbridge Pharmaceuticals | 1.39B |
| HighTide Therapeutics | 1.37B |